Age-Standardized Disability-Adjusted Life Years (DALYs) of Colorectal Cancer in Brunei Darussalam, 2002–2020: A Population-Based Registry Study

In the world of public health, counting how many people get sick or die is only the beginning of the story. To truly understand the weight of a disease on a society, experts look at something called Disability-Adjusted Life Years, or DALYs. This concept combines two different kinds of loss into a single number: the years of life lost because someone died too young, and the years spent living with the pain, limitations, or complications of an illness. Think of it as a way to measure the total amount of healthy time a population loses to a specific condition. While some diseases are famous for causing long periods of suffering, others are defined by how quickly they take lives. Understanding this balance helps governments decide where to focus their resources, whether that means investing in better treatments for the sick or launching screening programs to catch diseases before they become fatal.

In Brunei Darussalam, a small, high-income nation in Southeast Asia, researchers recently turned their attention to colorectal cancer, a type of bowel cancer that has been rising in frequency across the country. For nearly two decades, from 2002 to 2020, the national cancer registry tracked every person diagnosed with this disease. A team of scientists from Universiti Brunei Darussalam used this detailed record to calculate the total burden of colorectal cancer on the nation's health. They did not just count the cases; they calculated exactly how many healthy years were lost, separating the impact on men and women, looking at how the stage of the cancer at diagnosis changed the outcome, and examining whether the disease affected younger people differently than older ones. Their goal was to create a clear, national baseline that could help evaluate how well the country's future screening programs might work.

The study revealed that colorectal cancer imposes a heavy toll on Brunei, but the nature of that toll is starkly defined by death rather than long-term disability. Over the nineteen-year period, the disease accounted for more than 17,000 lost healthy years across the population. When the researchers broke down this number, they found that nearly 95 percent of the burden came from premature death, while only about 5 percent came from the time people lived with the disease. This means that for the vast majority of patients, the tragedy was not a long struggle with illness, but the sudden loss of life. The burden was higher for men than for women, reflecting the fact that more men were diagnosed and died from the disease, but the ratio of death to disability remained almost identical for both sexes.

The stage at which the cancer was found made a dramatic difference in the outcome. For patients whose cancer was caught early and remained localized to the bowel, the burden was lower, and a slightly larger portion of that burden came from living with the condition rather than dying from it. However, once the cancer had spread to nearby tissues or distant parts of the body, the picture changed completely. In these advanced stages, the loss of healthy years was driven almost entirely by death. The data showed that the further the cancer had spread, the more severe the outcome, with distant-stage cases contributing the largest share of the total national burden. This pattern confirms that for this disease, preventing death is the primary way to reduce the overall harm to the community.

One of the most striking findings concerned the age of the patients. While the majority of cases occurred in people over fifty, a significant portion—more than one in five—were diagnosed in people under fifty. These younger patients, though fewer in number, carried a disproportionately heavy burden. Because they had many more years of life ahead of them when they were diagnosed, their deaths resulted in a much larger loss of potential life compared to older patients. On average, each case of early-onset cancer cost the country nearly twice as many healthy years as a case in an older adult. This suggests that the rising trend of bowel cancer in younger people is not just a statistical curiosity, but a major driver of the total health loss the nation experiences.

The researchers also looked at how the burden changed over time. The total number of lost years rose steadily until 2015, driven largely by a cluster of deaths among very young patients in that specific year, before beginning to decline through 2020. This decline happened even though the population was getting older, a demographic shift that usually pushes disease rates up. The fact that the burden dropped despite an aging population suggests a genuine improvement in how the disease was being managed or detected toward the end of the study period. The team also tested their calculations by changing the mathematical rules they used to weigh the suffering of survivors. They found that the specific method used to measure disability mattered significantly; using a single, generic value for disability would have overestimated the total burden by nearly 6 percent compared to their more detailed, stage-specific approach.

Ultimately, this study provides the first clear picture of the total health cost of colorectal cancer in Brunei. It confirms that the disease is a major killer, with the vast majority of its impact coming from lives cut short rather than years spent in poor health. The findings highlight that while the number of cases is rising, the most effective way to reduce the national burden is to prevent deaths, particularly among younger people who stand to lose the most. By establishing this baseline, the researchers have given policymakers a concrete tool to measure the success of future screening efforts. If early detection programs are successful, the data suggests that the number of lost years should begin to fall, proving that catching the disease early can save not just lives, but the future of the community.